Who Is in the Driver's Seat: Tracing Cancer Genes Using CRISPR-Barcoding
- PMID: 27494556
- DOI: 10.1016/j.molcel.2016.07.013
Who Is in the Driver's Seat: Tracing Cancer Genes Using CRISPR-Barcoding
Abstract
Intratumor heterogeneity is thought to be the driving force of tumor evolution and therapy resistance. Yet tools to study these processes are limited. In this issue, Guernet et al. (2016) devised clustered regularly interspaced short palindromic repeats (CRISPR)-barcoding to functionally annotate specific mutations and study clonal evolution in heterogeneous cell populations.
Copyright © 2016. Published by Elsevier Inc.
Comment on
-
CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations.Mol Cell. 2016 Aug 4;63(3):526-38. doi: 10.1016/j.molcel.2016.06.017. Epub 2016 Jul 21. Mol Cell. 2016. PMID: 27453044 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources